Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DIM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalyst-free synthesis patent CN117263886A offers high-purity 2,5-tetrahydrofurandimethylamine with scalable cost reduction and supply chain reliability for global buyers.
Patent CN102617413B details a zero-discharge synthesis route for SIPM-SO3Na using high-concentration oleum, offering superior yield and environmental compliance for polyester manufacturers.
Patent CN1301246C details novel 1-cyano-1-(3,5-dimethoxyphenyl)-2-phenylethylene synthesis. Offers superior antitumor potential and scalable manufacturing for reliable pharmaceutical intermediate suppliers.
Novel method for synthesizing sugammadex sodium dimer impurity via sulfide bridging. Enhances quality control and reduces clinical risk for API manufacturers.
Patent CN111471121A details a novel two-step synthesis for Sugammadex Sodium dimer impurity, enhancing quality control and reducing analytical risks for global pharmaceutical manufacturers.
Patent CN102267913B reveals a safer TS-1 catalyzed route for 2,3-dimethyl-2,3-dinitrobutane. Eliminate toxic nitropropane precursors for high-purity explosive tracers.
Patent CN101648885A reveals a novel urea-based route for Dimer Diamide. Discover cost-effective manufacturing and scalable supply chain solutions for DDI precursors.
Novel 4-step route avoids hydrogenation, ensures 100% ee. Ideal for pharma intermediate supply chain optimization and cost reduction.
Patent CN105130808B enables cost reduction in pharmaceutical intermediates manufacturing via stable raw materials and simplified purification for reliable supply chain continuity.
Patent CN116496314A details a safer synthesis route for high-purity pharmaceutical intermediates. This method offers substantial cost reduction and enhanced supply chain reliability for global buyers.
Patent CN110845410B reveals a safe one-pot method for 6,7-dimethoxy-3,4-dihydroisoquinoline HCl using phosphotungstic acid, offering high purity and cost reduction.
Patent CN111517922B reveals a novel phosgene-based chlorination method for PCMX. Achieves high para-selectivity and reduced sulfide waste for reliable supply chains.
Novel palladium-free synthesis of vortioxetine intermediates ensures high yield and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN114195754B reveals a novel catalytic route for S-(-)-4-chloromethyl-2,2-dimethyl-1,3-dioxolane, offering superior chiral purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN1241890C reveals a scalable 3-step route for C10 dialdehyde monoacetals, offering safer reduction and catalytic oxidation for carotenoid manufacturing.
Novel patent CN115959977B reveals high-yield route for triphenol intermediates. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Patent CN101270058B details a high-yield hydrogenation route for 3-(1-dimethylaminoethyl)phenol, offering superior purity and cost efficiency for Alzheimer's drug intermediates.
Patent CN109824493A reveals a novel three-step Grignard route for 10,10-dimethyl anthrone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103159702B reveals novel guaiazulene sulfonylpiperazine synthesis offering enhanced anti-ulcer activity and scalable manufacturing processes for global supply chains.
Patent CN103833565B enables one-pot synthesis with high purity. Delivers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.